Volume 7, Number 1—February 2001
Research
Lack of Evidence of Endogenous Avian Leukosis Virus and Endogenous Avian Retrovirus Transmission to Measles Mumps Rubella Vaccine Recipients
Figure 3
![Reverse transcriptase-polymerase chain reaction analysis of sera from measles mumps rubella (MMR) vaccine recipients for the presence of avian leukosis virus (ALV) (A) and endogenous avian retrovirus (EAV) (B) RNA. Lanes 1-10, samples from MMR vaccine recipients. NC, negative control, uninfected human serum; PC, positive control, culture supernatant from Rous-associated virus 0 (RAV-0) infected 15B1 chick embryo fibroblasts.](/eid/images/70-0066-F3.jpg)
Figure 3. Reverse transcriptase-polymerase chain reaction analysis of sera from measles mumps rubella (MMR) vaccine recipients for the presence of avian leukosis virus (ALV) (A) and endogenous avian retrovirus (EAV) (B) RNA. Lanes 1-10, samples from MMR vaccine recipients. NC, negative control, uninfected human serum; PC, positive control, culture supernatant from Rous-associated virus 0 (RAV-0) infected 15B1 chick embryo fibroblasts.
Page created: March 16, 2011
Page updated: March 16, 2011
Page reviewed: March 16, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.